Morning Overview on MSN
A daily multivitamin just slowed all five epigenetic aging clocks in a randomized trial — the people who started biologically older showed the biggest benefit
A two-year randomized trial found that a daily multivitamin slowed biological aging across all five epigenetic clocks tested ...
A phase 1b/2, multicenter, open-label study to evaluate the efficacy and safety of GSK5764227 (GSK’227), alone and in combination in patients with previously treated advanced unresectable or ...
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized ...
Early administration of paracetamol may accelerate closure of the patent ductus arteriosus in extremely preterm babies, according to a new study.
Key milestone positions ART6043 as the most advanced Pol-theta inhibitor in clinical development; the potentially first-in-class program is ...
A randomized, double-blind, active-control, multicenter phase 3 trial of casdatifan and cabozantinib versus placebo and cabozantinib in patients with advanced clear cell RCC. Treatment options remain ...
Morning Overview on MSN
A daily multivitamin slowed all five epigenetic aging clocks in a randomized trial — people who started biologically older saw the biggest benefit
A standard daily multivitamin, the kind sold at every pharmacy for roughly a dime a dose, slowed biological aging across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results